Читать книгу Ból przewlekły - Группа авторов - Страница 15

2. Farmakoterapia bólu przewlekłego
Piśmiennictwo

Оглавление

1. Higginson IJ, Murtagh F. Cancer pain epidemiology. w: Bruera E, Portenoy RK (red.). Cancer Pain. Assessment and Management. Cambridge University Press 2010; 3: 37–52.

2. Breivik H, Cherny N, Collett F i wsp. Cancer-related pain: a pan European survey of prevalence, treatment, and patient attitudes. Ann Oncol 2009; 20: 1420–1433.

3. Van den Beuken-van Everdingen MHJ, De Rijke JM, Kessels AG i wsp. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007; 18: 1437–1449.

4. Mercadante S, Radbruch L, Caraceni A i wsp. Episodic (breakthrough) pain: consensus conference of the Expert Working Group of the European Association for Palliative Care. Cancer 2002; 94: 832–839.

5. Bennett M. Treatment of cancer pain. w: Tracey I (red.). Pain 2012. Refresher courses 14th World Congress on Pain. IASP Press, Seattle 2012: 301–316.

6. Caraceni A, Hanks G, Kaasa S i wsp. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 2012; 13: 58–68.

7. Fallon M, Giusti R, Aielli F i wsp., on behalf of the ESMO Guidelines Committee. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol 2018; 29 (Suppl 4): iv149–iv174.

8. Health Organization. Cancer Pain Relief. WHO, Geneva 1986.

9. Mercadante S. Pharmacological management of cancer pain. w: Mogil J (red.). Pain 2010. An Updated Review. Refresher Course Syllabus. IASP Press, Seattle 2010: 37–41.

10. Kalso E. Clinical pharmacology of opioids in the treatment of pain. w: Mogil J (red.). Pain 2010. An Updated Review. IASP Press, Seattle 2010: 207–216.

11. McPherson M. Opioid therapy for cancer pain. w: Tracey I (red.). Pain 2012. Refresher courses 14th World Congress on Pain. IASP Press, Seattle 2012: 319–326.

12. Hardy J, Nauck F. Opioids for cancer pain. w: Walsh D, Caraceni A, Fainsinger R (red.). Palliative Medicine. Saunders Elsevier, Philadelphia 2009: 1404–1411.

13. Reid CM, Gooberman Hill R, Hanks GW. Opioid analgesics for cancer pain: symptom control for the living or comfort for the dying? A qualitative study to investigate the factors influencing the decision to accept morphine for pain caused by cancer. Ann Oncol 2008; 19: 44–48.

14. Ahmedzai SH, Leppert W, Janecki M i wsp. Long-term safety and efficacy of oxycodone/naloxone prolonged–release tablets in patients with moderate-to-severe chronic cancer pain. Support Care Cancer 2015; 23: 823–830.

15. Leppert W, Wordliczek J, Malec-Milewska M i wsp. Recommendations for assessment and management of pain in cancer patients. Oncol Clin Pract 2018; 14: 1–14.

16. Finnerup NB, Attal N, Haroutounian S. i wsp. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015; 14: 162–173.

17. Leppert W. Pain Management in Patients with Cancer: Focus on Opioid Analgesics. Curr Pain Headache Rep 2011; 15: 271–279.

18. Garg R, Joshi S, Mishra S, Bhatnagar S. Evidence Based Practice of Chronic Pain. Ind J Palliat Care 2012; 18: 155–161.

19. Bhatnagar S, Gupta M. Evidence-Based Clinical Practice Guidelines for Interventional Pain Management in Cancer Pain. Ind J Palliat Care 2015; 21: 137–147.

20. Jarosz J, Kaczmarek Z, Kowalski DM i wsp. Postępowanie w bólach nowotworowych. w: Krzakowski M, Warzocha K (red.). Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych u dorosłych 2013 rok. Via Medica, Gdańsk 2013: 627–637.

Ból przewlekły

Подняться наверх